Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.
نویسنده
چکیده
The Journal of Clinical Investigation | May 2003 | Volume 111 | Number 9 14. Abramsson, A., et al. 2002. Analysis of mural cell recruitment to tumor vessels. Circulation. 105:112–117. 15. Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103:159–165. 16. Simon, M.P., et al. 1997. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet. 15:95–98. 17. Pietras, K., et al. 2002. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res. 62:5476–5484. 18. Heuchel, R., et al. 1999. Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling. Proc. Natl. Acad. Sci. U. S. A. 96:11410–11415. 19. Coussens, L.M., and Werb, Z. 2002. Inflammation and cancer. Nature. 420:860–867. 20. Luttun, A., et al. 2002. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8:831–840. 21. Schoppmann, S.F., et al. 2002. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161:947–956 22. Yancolpoulos, G.D., et al. 2000. Vascular-specific growth factors and blood vessel formation. Nature. 407:242–248. 23. Olofsson, B., et al. 1998. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 95:11709–11714. 24. Bergsten, E., et al. 2001. PDGF-D is a specific, protease-activated ligand for the PDGF-β–receptor. Nat. Cell Biol. 3:512–516. 25. LaRochelle, W.J., et al. 2001. PDGF-D, a new protease-activated growth factor. Nat. Cell Biol. 3:517–521.
منابع مشابه
Destructive effect of quinone-containing compounds on cytochrome P450: Arbutin as a double-edged sword
متن کامل
Overview on Evans syndrome: In the course of Covid-19 pandemic; essentials and approaches
Redundant studies proved coronavirus infection results from a defect in a suitable immune response that may exacerbate immune-inflammatory reactions like cytokine storm and autoimmunity. Evans syndrome (ES) is a rare chronic autoimmune disease that distinguishes it from autoimmune hemolytic anemia (AIHA) and immune thrombocytopenic purpura (ITP). Reports have shown significant differences in im...
متن کاملImmune mechanism: a 'double-edged sword'.
Immunology has now developed into an independent discipline in medicine which covers not only germ infection which is related to immunity solely but also covers a lot of non-infectious diseases such as autoimmune disease, allergies, and others. Therefore, "The Immune Mechanism: "A Double-Edged Sword" means that the immune mechanism (consisted of antibody mediated mechanism and T cell mediated m...
متن کاملThe Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis
The relationship between immune responses to self-antigens and autoimmune disease is unclear. In contrast to its animal model experimental autoimmune encephalomyelitis (EAE), which is driven by T cell responses to myelin antigens, the target antigen of the intrathecal immune response in multiple sclerosis (MS) has not been identified. Although the immune response in MS contributes significantly...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of clinical investigation
دوره 111 9 شماره
صفحات -
تاریخ انتشار 2003